Supervisory team
LSHTM
- Lead supervisor: Kaja Abbas ([email protected])
Nagasaki University
- Second supervisor: Hyolim Kang ([email protected])
External advisory committee
- Third supervisor: Noriko Kitamura, NU & Japan Institute for Health Security (JIHS)
- Fourth supervisor: Polina Brangel, CEPI (Coalition for Epidemic Preparedness Innovations)
- Fifth supervisor: Motoi Suzuki, NU & JIHS (Japan Institute for Health Security)
The project
Background
As part of the SCARDA (Strategic Center of Biomedical Advanced Vaccine Research and Development for Preparedness and Response) programme in Japan, the Vaccines, Therapeutics, and Diagnostics Research Development Center (VRDC), DEJIMA Infectious Disease Research Alliance (DIDA), Nagasaki University is developing new medical countermeasures against a range of infections, including high-consequence infections and tropical pathogens.
Proposed project
The research will involve developing AI-enabled mathematical models of the transmission dynamics of priority pathogens for SCARDA and CEPI. The AI-enabled infectious disease modelling framework will be impactful for decision-making on deployment strategies of medical countermeasures, as well as being adaptable to Disease X and a viral family (Henipaviruses, Orthopoxviruses, Coronaviruses, etc., from the roughly 25 viral families known to infect people) approach beyond specific pathogens. These models will be used to assess how medical countermeasures (vaccines, diagnostics, and therapeutics) could be used for prevention and control of infectious disease epidemics (e.g., responding to outbreaks or incorporated into routine prevention and control programmes).
The project could be structured around interconnected objectives and adapted using novel approaches. First, develop AI-enhanced epidemic intelligence systems by integrating surveillance, mobility, climate, and genomic data to improve outbreak detection and forecasting. Second, build and calibrate pathogen-specific transmission dynamic models using Bayesian and AI-assisted inference methods to better understand epidemic spread. Third, evaluate and optimise the deployment of vaccines, diagnostics, and therapeutics under different outbreak scenarios and resource constraints to support evidence-based decision-making. Fourth, develop a Disease X readiness framework by generalising these methods into adaptable modelling tools that can be rapidly applied to emerging pathogens, supporting the pandemic preparedness objectives of SCARDA and CEPI.
Complementing the research project, the prospective student will also act as a liaison across multilateral initiatives including the SCARDA programme in Japan, CEPI, and other pandemic preparedness initiatives and develop skills in science diplomacy. The student is expected to split their time between London, Nagasaki, and Tokyo.
References
- Kraemer MUG, Tsui JL, Chang SY, Lytras S, Khurana MP, Vanderslott S, Bajaj S, Scheidwasser N, Curran-Sebastian JL, Semenova E, Zhang M, Unwin HJT, Watson OJ, Mills C, Dasgupta A, Ferretti L, Scarpino SV, Koua E, Morgan O, Tegally H, Paquet U, Moutsianas L, Fraser C, Ferguson NM, Topol EJ, Duchêne DA, Stadler T, Kingori P, Parker MJ, Dominici F, Shadbolt N, Suchard MA, Ratmann O, Flaxman S, Holmes EC, Gomez-Rodriguez M, Schölkopf B, Donnelly CA, Pybus OG, Cauchemez S, Bhatt S. (2025). Artificial intelligence for modelling infectious disease epidemics. Nature, 638(8051):623-635. https://doi.org/10.1038/s41586-024-08564-w
- Adalja AA, Pannu J, Inglesby TV. (2026). AI and the future of medical countermeasures to protect against biological threats. Open Forum Infectious Diseases,13(3):ofag108. https://doi.org/10.1093/ofid/ofag108
- WHO. (2026). WHO Hub for Pandemic and Epidemic Intelligence strategy 2030, Public health intelligence for a safer world. https://hub2030.info/
- CEPI. Building a global AI platform for pandemic preparedness. https://cepi.net/building-global-ai-platform-pandemic-preparedness
- VRDC. Vaccines, Therapeutics, and Diagnostics Research Development Center, Nagasaki University. https://dida.nagasaki-u.ac.jp/vrdc-about-en/
The role of LSHTM and NU in this collaborative project
Nagasaki University is a synergistic partner of Japan AMED’s SCARDA (Strategic Center of Biomedical Advanced Vaccine Research and Development for Preparedness and Response) programme. The Vaccines, Therapeutics, and Diagnostics Research Development Center (VRDC), DEJIMA Infectious Disease Research Alliance (DIDA) at Nagasaki University focuses on tropical and high-risk infectious diseases and AI-driven development of medical countermeasures to support Japan's 100-day pandemic response mission.
LSHTM hosts CEPR (Centre for Epidemic Preparedness and Response), CMMID (Centre for Mathematical Modelling of Infectious Diseases), and the Vaccine Centre. The student will gain from this transdisciplinary research environment, resources, and expertise of cross-cutting interest to the proposed project. LSHTM is a partner in the Japan AMED SCARDA programme.
The Japan Institute for Health Security (JIHS) is a national public health agency established in 2025 through the merger of the National Center for Global Health and Medicine (NCGM) and the National Institute of Infectious Diseases (NIID) to serve as Japan’s central hub for infectious disease intelligence, scientific research, and clinical crisis response. JIHS is a partner in the Japan AMED SCARDA programme.
CEPI (Coalition for Epidemic Preparedness Innovations) is an international global partnership that accelerates the development of vaccines and other medical countermeasures against epidemic and pandemic threats to ensure they are equitably accessible to all people in need. CEPI’s 100-day mission and Japan's 100-day pandemic response mission are closely aligned.
Particular prior educational requirements for a student undertaking this project
Essential
- Knowledge of infectious disease epidemiology.
Desired
- Experience in infectious disease modelling;
- Proficiency in science communication.
Skills we expect a student to develop/acquire whilst pursuing this project
- Infectious disease modelling
- AI analytics for epidemic preparedness and response
- Science diplomacy in medical countermeasures.